pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 18·1 min read
save

CMS recalculates 2026 Medicare Advantage star ratings, increasing program volatility and affecting $16 billion in bonuses

Jun 18, 2026·read at STAT ↗RegulatoryNegative

Federal officials have issued a new memo that recalculates the quality ratings for 2026 Medicare Advantage plans.

The change follows another lawsuit from insurers that contest lower star ratings, which can jeopardize bonus payments.

Plans earning four or more stars qualify for bonus payments, and those bonuses have risen to roughly $16 billion this year.

Repeated legal challenges have forced CMS to redo the ratings before, and the latest adjustment adds further uncertainty for insurers.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: CMS recalculates Medicare Advantage star ratings again, adding more volatility to program”

read at STAT ↗
523 words · retrieved Jun 19
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
AdComMajor DepressionVaccine

related stories

  • Jun 18What’s next for GLP-1 weight loss drugs?STAT
  • Jun 17STAT+: DOJ’s swift win in OhioHealth case should have hospitals studying their contracts, experts saySTAT
  • Jun 17Luigi Mangione will assert psychiatric defense in murder case in UnitedHealthcare CEO’s killingSTAT
  • Jun 17STAT+: FDA appears open to Moderna’s flu vaccine ahead of adcommSTAT
  • Jun 17STAT+: Following dispute with FDA, UniQure is cleared to submit Huntington’s treatment for approvalSTAT